Search clinical trials for: Alicaforsen

Total 6 results

Ionis Pharmaceuticals, Inc.

Completed

Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease

Crohn's Disease

United States, Canada
Ionis Pharmaceuticals, Inc.

Completed

ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis

Ulcerative Colitis

United States
Atlantic Pharmaceuticals Ltd

Completed

Phase 1 Food Effect Study for Alicaforsen Tablets

IBD

United Kingdom
Atlantic Pharmaceuticals Ltd

Completed

Efficacy of Alicaforsen in Pouchitis Patients Who Have Failed to Respond to at Least One Course of Antibiotics

Pouchitis

United States, Belgium, Canada, France, Ireland, Israel, Italy, Netherlands, Switzerland, United Kingdom
Ionis Pharmaceuticals, Inc.

Completed

ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.

Ulcerative Colitis

United States
Ionis Pharmaceuticals, Inc.

Completed

Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease

Crohn's Disease

Poland, Spain, Belgium, Germany, Czechia, Italy

3

Subscribe